Radiofrequency Ablation Devices Market Size, Share, Growth Analysis, Product (Disposable, Reusable), By Application (Cardiology & Cardiac Rhythm Management, Surgical Oncology), By End Users (Hospitals, Specialty Clinics), By Region -Industry Forecast 2024-2031


Report ID: SQMIG35A2903 | Region: Global | Published Date: September, 2024
Pages: 200 |Tables: 0 |Figures: 0

Radiofrequency Ablation Devices Market Insights

Global Radiofrequency Ablation Devices Market size was valued at USD 4.34 Billion in 2022 and is poised to grow from USD 4.85 Billion in 2023 to USD 11.66 Billion by 2031, growing at a CAGR of 11.6% in the forecast period (2024-2031).

As the name suggests, the radiofrequency ablation devices market includes medical devices or equipment that treat different conditions like chronic pain, tumors, and other severe diseases through the application of radiofrequency energy to aim the damaging tissues. The market is significantly progressing on the back of the rising incidences of chronic disorders, the increasing demand for less invasive surgeries, and improvements in technologies. The market is also propelled by the mounting number of cancer cases and a significant inclination to outpatient procedures. Nonetheless, the market is restrained by significantly priced radiofrequency ablation devices, which could restrict their adoption in the middle income and underdeveloped nations. The market is also negatively impacted by the lack of skilled experts in several developing regions. Despite these restraints, the radiofrequency ablation devices market is opportune to the speedily developing markets and continuous advancements in RFA technologies like integration with imaging systems and enhanced electrodes design.

Market Snapshot - 2024-2031

Global Market Size

USD 4.34 Billion

Largest Segment

Disposable Equipment

Fastest Growth

Surgical Oncology

Growth Rate

11.6% CAGR

Global Radiofrequency Ablation Devices Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Radiofrequency Ablation Devices Market Segmental Analysis

The Global Radiofrequency Ablation Devices Market is segmented based on Product, Application, and Region. Based on Product, the market is divided into Disposable Equipment, Capital Equipment, Reusable Equipment. Based on Application, the market is divided into Surgical Oncology, Cardiology & Cardiac Rhythm Management, Cosmetology, Gynecology, Pain Management. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Analysis by Product

Based on product, the radiofrequency ablation devices market is segmented as disposable equipment, capital equipment, reusable equipment. The disposable equipment segment registered for a larger market share in 2023 and is anticipated to lead over the estimated period as well owing to the increasing need for disposable products for optimal safety and better prevention of cross-contamination. Disposable equipment includes catheters, electrodes, and probes that generally lead in terms of preference. They are comparably less priced than capital equipment and contribute to major recurring returns. These factors along with their compliance with hygiene standards are propelling the segment’s growth.

Conversely, the reusable equipment segment is expected to emerge as the fastest-growing segment owing to its higher preference since they reduce overall expenses. Reusable equipment is comparatively economical compared to disposable equipment replaced after every surgery. Clinics and hospitals increasingly use reusable products, mainly for used devices like probes and electrodes. The segment growth is also fueled by the rising focus on sustainability and lessening medical wastage since reusable equipment complies with these objectives.

Analysis by Application

Based on application, the radiofrequency ablation devices market is categorized into surgical oncology, cardiology & cardiac rhythm management, cosmetology, gynecology, pain management. The cardiology & cardiac rhythm management segment held a dominant share of the market in the previous years and will lead in the future as well owing to the increasing cases of cardiac arrhythmias. The growing patient population of arrhythmias like atrial fibrillation is fueling the need for RFA surgeries. The said procedure is highly effective in curing these disorders by ablating irregular heart tissues, increasing its preference for cardiac rhythm management. Moreover, innovations and advancements in RFA equipment have increased its safety and efficiency in cardiac surgeries, thus the segment’s growth.

Conversely, the surgical oncology segment is anticipated to hold a leading market share over the estimated period owing to increasing cases of cancers like lung, liver, and kidney. RFA ablates tumors and is comparatively less painful than former surgery techniques for specific cancer forms. In addition, RFA holds advantages for tumor ablation since it is highly effective for curing localized, small, and for patients who have not undergone traditional surgeries. These factors will drive the growth of the segment in the coming years.

Global Radiofrequency Ablation Devices Market Size By Product

To get detailed analysis on other segments, Request For Free Sample Report

Radiofrequency Ablation Devices Market Regional Insights

Geographically, North America is the dominating region among others and is expected to lead over the forecast period owing to well-developed healthcare infrastructure, especially in Canada and the United States that have easy access to technologically improved medical technologies like RFA devices. The regional growth is also impacted by growing cases of chronic diseases that demand efficient and safe radiofrequency ablation treatments and heavy investments in innovation and research and development. Also, favorable reimbursement policies and high healthcare spending is contributing to the adoption of improved medical devices like RFA devices. The prominent players operating in North America include AngioDynamics, Boston Scientific Corporation, Ethicon Inc., Medtronic, Philips, and more.

Asia-Pacific is the fastest-growing region among others due to growing healthcare infrastructure in key nations like India, China, and Japan. Growing investments in healthcare technology and speedy development are economies that drive the adoption and availability of RFA devices. Moreover, the rising cases of chronic illnesses like cardiovascular and cancer are propelling the demand for RFA treatments. The growing patient population is also offering a major boost for RFA devices, thus the market growth in the region.

Global Radiofrequency Ablation Devices Market Size By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Radiofrequency Ablation Devices Market Dynamics

Drivers

Minimally Invasive Procedures and Growing Elderly Population

  • The demand for minimally invasive procedures is significantly increasing owing to its benefits over conventional procedures, comprising less infection risk, short recovery times, and comparatively less postoperative pain. The globally increasing aging population is highly prone to conditions that need RFA treatment like chronic disease pain and tumors. The growing demographic inclination is fueling the market growth.

Regulatory Approvals and R&D

  • Favorable regulatory approvals and frameworks from EMA and FDA like agencies are supporting the adoption and development of novel radiofrequency ablation technologies, impacting the growth of the market. In addition, the ongoing clinical trials and research studies are increasing clinical indications for radiofrequency for radiofrequency ablation, resulting in novel applications and market growth.

Restraints

Side-Effects and Complication Risks

  • Despite radiofrequency ablation is less-invasive procedure, it still comprises risks like bleeding, damage to nearby tissues, and infections. Such concerns regarding associated complications may create hesitation among providers and patients from preferring RFA. The market is also restrained by the lack of skilled experts in a few regions, limiting the use of RFA technology.

Availability of Substitute Treatments

  • The availability of substitute treatment approaches like laser ablation, cryoablation, and chemotherapy may hinder the share of RFA devices. The treatment choice is mostly dependent on certain patient preferences and conditions. Moreover, economic fluctuations may notably affect medical investments, innovations, and advancements in technologies, thus restraining the growth of the market.

Request Free Customization of this report to help us to meet your business objectives.

Radiofrequency Ablation Devices Market Competitive Landscape

The global radiofrequency ablation devices market is a highly competitive global market driven by many international competitors. Prominent corporations with cutting-edge AI and ML technology are Google, IBM, Microsoft, and NVIDIA. To support a wide range of applications across industries, these industry experts concentrate on creating cutting-edge algorithms, scalable platforms, and reliable infrastructure. Rapid advances in technology, strategic alliances, and large expenditures on research and development define the competitive environment.

Top Player’s Company Profiles

  • Medtronic plc
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Stryker Corporation
  • ConMed Corporation
  • AtriCure, Inc.
  • Halyard Health
  • Cook Medical
  • Biosense Webster
  • IntraTherm
  • Rex Medical
  • Lumenis Ltd.
  • Cynosure

Recent Developments

  • In January 2024, Boston Scientific Corporation stated that it received the U.S. FDA approval for its FARAPULSE™ Pulsed Field Ablation (PFA) System. The said device is an exceptional substitute to the regular SOC thermal ablation treatment and is dedicated for isolating pulmonary veins for treating drug, recurrent, refractory, paroxysmal atrial fibrillation (AF), and symptomatic.
  • In August 2023, Medtronic stated that its revised ClosureFast™ radiofrequency ablation (RFA) catheter (in low 6F profile) receive clearance from the U.S. FDA. The said procedure is dedicated to help cure CVI (chronic venous insufficiency), a progressive condition that impacts leg veins that returns blood to the heart.
  • In July 2024, Stryker introduced MultiGen 2 Radiofrequency (RF) Generator, which offers optimal efficiency, reliability, and control to the physicians that require while performing radiofrequency ablation.

Radiofrequency Ablation Devices Key Market Trends

  • (PFA) Pulsed Field Ablation: Pulsed-field ablation has lately gained traction as a progressive technology for ablation. It makes use of large electrodes to decrease current density. This technology is for non-thermal ablation. Based on recent studies, myocardium is highly susceptible to the effects of PFA compared to other tissues, mainly the nerves and esophagus.
  • Microwave Endometrial Ablation: Endometrial ablation is another domain that is transforming the way gynecological diseases are treated. Microwave endometrial ablation is a novel treatment for dysfunctional bleeding of uterine that comprises application of microwave power to endometrium. A few other advancements progressing in ablation devices segment comprise electrophysiology mapping, cardiac ablation, and cancer ablation devices.

Radiofrequency Ablation Devices Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

As per SkyQuest analysis, radiofrequency ablation devices market is progressing at a notable rate supported by drivers like the growing number of less invasive procedures, increasing acceptance and adoption of RFA technologies, and developing healthcare infrastructure. Nevertheless, the market is negatively affected by reimbursement and limited coverage issues, technological variability and limitations, and access to competitive alternatives. North America is projected to dominate the market due to the growing patient population of chronic illnesses, strong healthcare spending, and innovations. Yet, increasing outpatient population, growing awareness and education about the said technology, and trend towards personalized medicines are a few opportunities in the radiofrequency ablation devices market.

Report Metric Details
Market size value in 2022 USD 4.34 Billion
Market size value in 2031 USD 11.66 Billion
Growth Rate 11.6%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product
    • Disposable Equipment, Capital Equipment, and Reusable Equipment
  • Application
    • Surgical Oncology, Cardiology & Cardiac Rhythm Management, Cosmetology, Gynecology, and Pain Management
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Medtronic plc
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Stryker Corporation
  • ConMed Corporation
  • AtriCure, Inc.
  • Halyard Health
  • Cook Medical
  • Biosense Webster
  • IntraTherm
  • Rex Medical
  • Lumenis Ltd.
  • Cynosure
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

 

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Radiofrequency Ablation Devices Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Radiofrequency Ablation Devices Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Radiofrequency Ablation Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Radiofrequency Ablation Devices Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Radiofrequency Ablation Devices Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Radiofrequency Ablation Devices Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Radiofrequency Ablation Devices Market size was valued at USD 4.34 Billion in 2022 and is poised to grow from USD 4.85 Billion in 2023 to USD 11.66 Billion by 2031, growing at a CAGR of 11.6% in the forecast period (2024-2031).

The global radiofrequency ablation devices market is a highly competitive global market driven by many international competitors. Prominent corporations with cutting-edge AI and ML technology are Google, IBM, Microsoft, and NVIDIA. To support a wide range of applications across industries, these industry experts concentrate on creating cutting-edge algorithms, scalable platforms, and reliable infrastructure. Rapid advances in technology, strategic alliances, and large expenditures on research and development define the competitive environment. 'Medtronic plc', 'Boston Scientific Corporation', 'Johnson & Johnson', 'Abbott Laboratories', 'AngioDynamics, Inc.', 'Stryker Corporation', 'ConMed Corporation', 'AtriCure, Inc.', 'Halyard Health', 'Cook Medical', 'Biosense Webster', 'IntraTherm', 'Rex Medical', 'Lumenis Ltd.', 'Cynosure'

The demand for minimally invasive procedures is significantly increasing owing to its benefits over conventional procedures, comprising less infection risk, short recovery times, and comparatively less postoperative pain. The globally increasing aging population is highly prone to conditions that need RFA treatment like chronic disease pain and tumors. The growing demographic inclination is fueling the market growth.

(PFA) Pulsed Field Ablation: Pulsed-field ablation has lately gained traction as a progressive technology for ablation. It makes use of large electrodes to decrease current density. This technology is for non-thermal ablation. Based on recent studies, myocardium is highly susceptible to the effects of PFA compared to other tissues, mainly the nerves and esophagus.

Geographically, North America is the dominating region among others and is expected to lead over the forecast period owing to well-developed healthcare infrastructure, especially in Canada and the United States that have easy access to technologically improved medical technologies like RFA devices. The regional growth is also impacted by growing cases of chronic diseases that demand efficient and safe radiofrequency ablation treatments and heavy investments in innovation and research and development. Also, favorable reimbursement policies and high healthcare spending is contributing to the adoption of improved medical devices like RFA devices. The prominent players operating in North America include AngioDynamics, Boston Scientific Corporation, Ethicon Inc., Medtronic, Philips, and more.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Report ID: SQMIG35A2903

$5,300
BUY NOW GET FREE SAMPLE